Safety and efficacy of praziquantel in pregnant women infected with Schistosoma haematobium in Lambaréné, Gabon - Clinical results from the randomized, single-blinded, controlled freeBILy-Gabon trial

Int J Infect Dis. 2024 Dec:149:107253. doi: 10.1016/j.ijid.2024.107253. Epub 2024 Oct 4.

Abstract

Objectives: Despite evidence of praziquantel's (PZQ) safety for treating schistosomiasis in pregnancy, many countries withhold treatment. Only two randomized controlled trials have investigated PZQ in pregnancy, none involving Schistosoma haematobium.

Methods: Pregnant women during the second trimester in Lambaréné (Gabon) were screened for S. haematobium infection using urine microscopy and circulating anodic antigen detection. Participants positive for either test were randomized (3:1) to single-dose PZQ 40 mg/kg during pregnancy versus no treatment during pregnancy. Investigators were blinded for allocation. Primary outcomes were reduction of egg (egg reduction rate [ERR]) and antigen production (infection reduction rate [IRR]) while explorative outcomes included assessment of cure rate, adverse events, maternal hemoglobin levels, maternal anemia prevalence at delivery, pregnancy outcomes, and newborn anthropometric parameters.

Results: Of 761 women screened 165 were eligible and randomized (intervention n = 124, control n = 41). Of them, 124 completed the study (n = 90 and n = 34, respectively). Treatment led to a significantly higher ERR (95.0% [91-97%] vs 27.0% [-42-63%]) and IRR (95% [91-97%] vs 56% [14-78%]). Common adverse events were dizziness, nausea, and vomiting. Maternal anemia at delivery was significantly lower in the intervention group (odds ratio: 0.40 [0.16;0.96], P = 0.04). No increased risk for adverse pregnancy outcomes was observed.

Conclusions: This first randomized controlled trial investigating PZQ in pregnant women with S. haematobium found PZQ to be safe, effective, and reducing maternal anemia. We recommend treating confirmed infections to prevent morbidity in pregnant women.

Keywords: Efficacy; Praziquantel; Pregnancy; S. haematobium; Safety; Schistosomiasis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Anemia / drug therapy
  • Animals
  • Anthelmintics* / administration & dosage
  • Anthelmintics* / adverse effects
  • Anthelmintics* / therapeutic use
  • Female
  • Gabon / epidemiology
  • Humans
  • Praziquantel* / administration & dosage
  • Praziquantel* / adverse effects
  • Praziquantel* / therapeutic use
  • Pregnancy
  • Pregnancy Complications, Parasitic* / drug therapy
  • Pregnancy Complications, Parasitic* / parasitology
  • Pregnancy Outcome
  • Schistosoma haematobium* / drug effects
  • Schistosomiasis haematobia* / drug therapy
  • Schistosomiasis haematobia* / epidemiology
  • Single-Blind Method
  • Treatment Outcome
  • Young Adult

Substances

  • Praziquantel
  • Anthelmintics